February 2011 - Page 16 of 25

ThursdayFeb 10, 2011 8:51 am

EGPI Firecreek, Inc. (EFIR.OB) Subsidiary Partners with Major Community College in New England

EGPI Firecreek, Inc. announced yesterday that a major community college in New England and Terra Telecom, Inc. (EGPI Firecreek, Inc.'s subsidiary) have formed a strong partnership aimed at constantly improving the college’s communication network to better serve student needs. Terra Telecom, Inc. is a leading provider of state-of-the-art communications technologies. Terra Telecom also works with the United Nations, delivering voice products to several countries, and the Texas Dept. of Transportation, which may bring significant opportunities to EGPI Firecreek, Inc. through various ITS/DOT opportunities. The college, with more than 30,000 students, is one of the largest and most innovative community colleges…

ThursdayFeb 10, 2011 8:47 am

Eternal Energy Corp. (EERG) Reports Update on Oil Projects in North America

Eternal Energy Corp. reported an operational update on its oil and gas activities in North America, where the company is active in developing properties prospective for the Bakken and Three Forks formations. Eternal Energy Corp. reported that the Hardy 7-9 well was taken off production in January 2011 due to mechanical problems. The well was producing 58 barrels of oil per day prior to this incident, up from 40 barrels of oil per day when it was first recompleted. Eternal Energy Corp. is having repair work performed and expects the well to be returned to production as soon as possible.…

WednesdayFeb 09, 2011 3:51 pm

Xenonics Holdings, Inc. (XNNH) Reports Q1 Results for 2011 Fiscal Year

Xenonics Holdings, Inc., the designer, manufacturer, and marketer of portable illumination products and night vision systems, announced today its net income for the first quarter of fiscal year 2011, which ended December 31,2010. The company reported a net income of $742,000, or $0.03 per basic share, on revenue of $3,548,000. This was a great improvement from last year’s Q1 net loss of $405,000, or $0.02 per basic share, on revenue of $1,255,000. "Based on orders in hand and current shipment schedules, we expect to report a profit again in the second quarter, and we are optimistic about the outlook for…

WednesdayFeb 09, 2011 2:17 pm

Biomoda (BMOD.OB) to Co-host Nationally Syndicated Radio Cancer Survivor Interviews

Biomoda Inc., a cancer diagnostics company, today announced that over the next two weeks CEO Maria Zannes and talk show host Stu Taylor will interview lung cancer survivors on a series of nationally syndicated business radio talk shows. The interviews will discuss Biomoda’s technology and funding for lung cancer research, as well as the importance of early detection. The statistics of lung cancer deaths in the United States is staggering; in a press release, Zannes noted the importance for continued search for advanced and innovative technologies to battle lung cancer, and her confidence in her company to do so. “Lung…

WednesdayFeb 09, 2011 11:30 am

First Liberty Power Corp. (FLPC.OB) is “One to Watch”

First Liberty Power Corp. is a Nevada based mineral exploration company that lists on the OTC Bulletin Board. The Company's primary focus is lithium exploration and development in the United States. The Company is in a position to capitalize on the anticipated increase in demand for lithium carbonate, projected to result from the acceleration of the adoption and use of clean renewable energy products that utilize lithium-ion batteries. Lithium is a soft, silver-white metal that belongs to the alkali metal group of chemical elements. Under standard conditions, it is the lightest metal and the least dense solid element. Lithium occurs…

WednesdayFeb 09, 2011 11:26 am

2010 Financial Results Announced by ImmuCell Corp. (ICCC)

ImmuCell Corp. is a biotechnology company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries. The company's product focus encompasses prevention, diagnosis and treatment of economically important bovine diseases. The company today announced the results of its operations for the fourth quarter and year ended December 31, 2010. In the fourth quarter, ImmuCell's product sales increased by 9 percent compared to the prior year to $1.123 million. For the year ended December 31, 2010, product sales for ImmuCell fell by 3 percent as compared to last year to $4.386 million.…

WednesdayFeb 09, 2011 11:24 am

GeoVax Labs Inc. (GOVX.OB) Opens Second Clinical Trial Site for HIV Vaccine

Today, GeoVax Labs, Inc. announced that it has opened a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial. This trial marks the first clinical trial that uses the same products for treatment of persons who already have the HIV infection. The study will last up to 77 weeks for each participant. To be eligible, volunteers need to be diagnosed within the first year of HIV infection and they must have started antiretroviral drug therapy within six months of diagnosis. Researchers will…

WednesdayFeb 09, 2011 11:23 am

Norsat International Inc. (NSATF.OB) Announces New RFID Products

Leading broadband communications solutions provider, Norsat International Inc. yesterday announced that its Microwave Business Unit will now offer RFID on-metal tags and readers as part of its microwave components product line. The RFID reader provides an automated solution for ensuring product security and managing inventory and product warranty. Offering a compact, light weight and economical method for tracking and monitoring assets, the Norsat RFID tag can be read when adhered to metal surfaces, and is best used with vehicles, baggage, products and inventory. Norsat revealed its new product line on February 8, 2011 at CABSAT MENA 2011 at the Dubai…

WednesdayFeb 09, 2011 11:20 am

PolyMedix (PYMX.OB) Initiates Phase II Clinical Trials of Anticoagulant to Address Unmet Medical Needs

PolyMedix Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, today announced it has commenced a phase II clinical trial to assess the safety and efficacy of its anticoagulant PMX -60056 to reverse post-operative bleeding (heparin) in patients undergoing Percutaneous Coronary Intervention (PCI) procedures. The clinical study follows conclusion of a review by the United States Food and Drug Administration (FDA) of a protocol submitted by PolyMedix to evaluate PMX-60056 by intravenous infusion. The study is expected to be available at the end of the year, and the company said…

WednesdayFeb 09, 2011 11:19 am

Dr. Ella Frekel Speaks on the Past and Future of Simulated Environment Concepts, Inc. (SMEV.PK)

Last week, Dr. Ella Frenkel, the President and CEO of Simulated Environment Concepts, Inc., gave a speech summarizing the company, what has been accomplished over the past year, and where the company is headed. The speech was given at an especially active time for SE Concepts, makers of the SpaCapsule® hydro-massage and personal sensory system. January was by far the biggest single month in the history of the company, but just the beginning of what Dr. Frenkel called “a path of explosive growth”. Dr. Frenkel began by describing the history of SE Concepts, from its founding in 2000, to the…

Site Search

Company Search

Month: February 2011